GlassScriptPhysician profile
Alicia Ferrell Rector
NPI 1861603235
$3,223.97
in general payments reported to CMS, 2019-2025
40 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $855 · 2022: $874 · 2023: $634 · 2024: $467 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.39 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $605.57 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $259.89 | 2021-2025 | |
| Astellas Pharma US INC | $221.34 | 2021-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $210.05 | 2021-2024 | |
| Daiichi Sankyo INC. | $200.47 | 2021-2025 | Injectafer |
| Pfizer INC. | $135.36 | 2022-2025 | |
| Currax Pharmaceuticals LLC | $112.46 | 2021-2022 | |
| Biogen, INC. | $94.26 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $92.07 | 2023-2025 | Gemtesa, Myfembree |
| Organon LLC | $87.27 | 2021-2025 | Jada System, Nexplanon |
| Therapeuticsmd, INC. | $86.42 | 2021-2022 | |
| Evofem Biosciences, INC. | $82.89 | 2021-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $80.82 | 2021-2023 | Slynd |
| Novo Nordisk INC | $74.14 | 2021 | |
| Mission Pharmacal Company | $70.01 | 2023 | Citranatal |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Ferrell Rector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.